CHEMTRAK INC/DE
10-C, 1996-05-22
IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Previous: DURA PHARMACEUTICALS INC/CA, S-3MEF, 1996-05-22
Next: CELOX LABORATORIES INC, DEF 14A, 1996-05-22



<PAGE>   1
FORM 10-C


Securities and Exchange Commission
Washington, DC 20549


Report by issuer of securities quoted on The Nasdaq Stock Market(SM), filed
pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 and Rule
13a-17 or 15d-17 thereunder.

EXACT NAME OF ISSUER AS SPECIFIED IN CHARTER:  ChemTrak Incorporated
                                             -----------------------------------

                                         929 East Arques Avenue, 
ADDRESS OF PRINCIPAL EXECUTIVE OFFICES:  Sunnyvale, CA 94086
                                       -----------------------------------------

ISSUER'S TELEPHONE NUMBER (INCLUDING AREA CODE):  (408) 773-8156
                                                --------------------------------

I. Change in Number of Shares Outstanding
Indicate any change (increase or decrease) of five percent or more in the
number of shares outstanding:

1. Title of Security  Common Stock
                    ------------------------------------------------------------

2. Number of shares outstanding after the change  9,750,272
                                                --------------------------------

3. Number of shares outstanding after the change  11,698,372
                                                --------------------------------

4. Effective date of change  6/27/96 - 6/27/98
                           -----------------------------------------------------

5. Method of change  Conversion of convertible debentures
                   -------------------------------------------------------------

Specify method (such as merger, acquisition, exchange, distribution, stock
split, reverse split, acquisition of stock for treasury, etc.)------------------

- --------------------------------------------------------------------------------

                                        up to $5,000,000 in convertible 
                                        debentures issued 5/13/96 Conversions  
Give brief description of transaction   over a 2 year period beginning 6/27/96.
                                      ------------------------------------------

II. Change in Name of Issuer

1. Name prior to change
                       ---------------------------------------------------------

2. Name after change
                    ------------------------------------------------------------

3. Effective date of charter amendment changing name
                                                    ----------------------------

4. Date of shareholder approval of change, if required
                                                      --------------------------

                    /s/ PRITHIPAL BINGH, Ph.D.
- --------------------------------------------------------------------------------
DATE                OFFICER'S SIGNATURE AND TITLE
May 22, 1996        Prithipal Bingh, Ph.D.
                    Chairman of the Board and Chief Executive Officer



(c) June 1994, The Nasdaq Stock Market, Inc. All rights reserved, Nasdaq is a
    registered service mark of The Nasdaq Stock Market, Inc. The Nasdaq Stock
    Market is a service mark of The Nasdaq Stock Market, Inc.


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission